PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.\', \'Section of Pulmonary and Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT 06520.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520; and.\', \'Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520.\', \'Section of Pulmonary and Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT 06520; charles.delacruz@yale.edu bosioc@niaid.nih.gov.\', \'Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840; charles.delacruz@yale.edu bosioc@niaid.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.4049/jimmunol.2001025
?:doi
?:hasPublicationType
?:journal
  • Journal of immunology (Baltimore, Md. : 1950)
is ?:pmid of
?:pmid
?:pmid
  • 33277388
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all